Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 503112604

Selleck Chemical LLC Lenvatinib Mesylate S5240-1g
SDP

Catalog No. 503112604
Encompass_Preferred

Lenvatinib Mesylate is a synthetic orally available tyrosine kinase inhibitor that inhibits vascular endothelial growth factor receptor (VEGFR1-3) fibroblast growth factor receptor (FGFR1-4) platelet-derived growth factor receptor (PDGFR ) stem cell factor receptor (Kit (c-Kit)) and rearranged during transfection (RET (c-RET)) Lenvatinib Mesylate has potential antineoplastic activity

Catalog No. 50-311-2604 Supplier Selleck Chemical LLC Supplier No. S52401G
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Lenvatinib Mesylate is a synthetic orally available tyrosine kinase inhibitor that inhibits vascular endothelial growth factor receptor (VEGFR1-3) fibroblast growth factor receptor (FGFR1-4) platelet-derived growth factor receptor (PDGFR ) stem cell factor receptor (Kit (c-Kit)) and rearranged during transfection (RET (c-RET)) Lenvatinib Mesylate has potential antineoplastic activity

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.